(AIR) Airbus SE - Ratings and Ratios
Commercial Aircraft, Helicopters, Defence Systems, Space
Dividends
| Dividend Yield | 1.52% |
| Yield on Cost 5y | 3.38% |
| Yield CAGR 5y | 36.63% |
| Payout Consistency | 74.0% |
| Payout Ratio | 31.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.7% |
| Value at Risk 5%th | 48.3% |
| Relative Tail Risk | -4.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.90 |
| Alpha | 22.26 |
| CAGR/Max DD | 0.94 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.661 |
| Beta | 0.185 |
| Beta Downside | 0.410 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.08% |
| Mean DD | 6.24% |
| Median DD | 3.98% |
Description: AIR Airbus SE December 02, 2025
Airbus SE (PA: AIR) designs, manufactures and delivers a broad portfolio of aeronautics and aerospace products through three operating segments: commercial aircraft (Airbus), civil and military helicopters (Airbus Helicopters), and defence-space systems (Airbus Defence & Space). The commercial segment covers passenger jets, freighters, regional turboprops and component sales plus conversion services; the helicopter unit supplies both civil and military rotorcraft; the defence-space arm provides manned/unmanned air systems, satellite and launch services, and cyber-security solutions. The company, incorporated in 1998 and headquartered in Leiden, Netherlands, rebranded from Airbus Group SE to Airbus SE in April 2017.
Key quantitative drivers as of FY 2023 include a reported revenue of €78 billion, a commercial-aircraft backlog of roughly €150 billion, and an A320neo family market share of about 60 % in the narrow-body segment. Airbus’s defence-space revenue grew ~5 % year-over-year, reflecting increased sovereign spending on space-based communications and Earth-observation assets. Macro-level, the sector is sensitive to airline capacity-utilisation cycles, global defence budgets (which are rising at a 3-4 % CAGR), and supply-chain constraints on composite materials and semiconductors.
If you want a data-rich, side-by-side comparison of Airbus’s valuation multiples and scenario-based forecasts, you might explore the ValueRay platform for further analysis.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (5.07b TTM) > 0 and > 6% of Revenue (6% = 4.33b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 1.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.74% (prev 12.41%; Δ -0.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 7.43b > Net Income 5.07b (YES >=105%, WARN >=100%) |
| Net Debt (5.18b) to EBITDA (10.29b) ratio: 0.50 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (789.4m) change vs 12m ago -0.42% (target <= -2.0% for YES) |
| Gross Margin 15.54% (prev 15.01%; Δ 0.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.87% (prev 54.33%; Δ 2.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.97 (EBITDA TTM 10.29b / Interest Expense TTM 824.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.51
| (A) 0.07 = (Total Current Assets 69.41b - Total Current Liabilities 60.94b) / Total Assets 129.67b |
| (B) 0.15 = Retained Earnings (Balance) 19.32b / Total Assets 129.67b |
| (C) 0.06 = EBIT TTM 7.39b / Avg Total Assets 126.86b |
| (D) 0.20 = Book Value of Equity 20.12b / Total Liabilities 102.33b |
| Total Rating: 1.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.39
| 1. Piotroski 7.50pt |
| 2. FCF Yield 2.20% |
| 3. FCF Margin 4.96% |
| 4. Debt/Equity 0.50 |
| 5. Debt/Ebitda 0.50 |
| 6. ROIC - WACC (= 9.61)% |
| 7. RoE 22.04% |
| 8. Rev. Trend 32.15% |
| 9. EPS Trend -7.94% |
What is the price of AIR shares?
Over the past week, the price has changed by -3.63%, over one month by -7.44%, over three months by +5.44% and over the past year by +30.70%.
Is AIR a buy, sell or hold?
What are the forecasts/targets for the AIR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 224.4 | 13.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 246.4 | 25.1% |
AIR Fundamental Data Overview November 25, 2025
Market Cap EUR = 160.05b (160.05b EUR * 1.0 EUR.EUR)
P/E Trailing = 31.6303
P/E Forward = 25.0627
P/S = 2.2182
P/B = 6.7799
P/EG = 1.182
Beta = 0.937
Revenue TTM = 72.15b EUR
EBIT TTM = 7.39b EUR
EBITDA TTM = 10.29b EUR
Long Term Debt = 7.17b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.37b EUR (from shortTermDebt, last quarter)
Debt = 13.52b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.18b EUR (from netDebt column, last quarter)
Enterprise Value = 162.31b EUR (160.05b + Debt 13.52b - CCE 11.26b)
Interest Coverage Ratio = 8.97 (Ebit TTM 7.39b / Interest Expense TTM 824.0m)
FCF Yield = 2.20% (FCF TTM 3.58b / Enterprise Value 162.31b)
FCF Margin = 4.96% (FCF TTM 3.58b / Revenue TTM 72.15b)
Net Margin = 7.02% (Net Income TTM 5.07b / Revenue TTM 72.15b)
Gross Margin = 15.54% ((Revenue TTM 72.15b - Cost of Revenue TTM 60.94b) / Revenue TTM)
Gross Margin QoQ = 16.42% (prev 14.76%)
Tobins Q-Ratio = 1.25 (Enterprise Value 162.31b / Total Assets 129.67b)
Interest Expense / Debt = 1.34% (Interest Expense 181.0m / Debt 13.52b)
Taxrate = 33.52% (547.0m / 1.63b)
NOPAT = 4.91b (EBIT 7.39b * (1 - 33.52%))
Current Ratio = 1.14 (Total Current Assets 69.41b / Total Current Liabilities 60.94b)
Debt / Equity = 0.50 (Debt 13.52b / totalStockholderEquity, last quarter 27.25b)
Debt / EBITDA = 0.50 (Net Debt 5.18b / EBITDA 10.29b)
Debt / FCF = 1.45 (Net Debt 5.18b / FCF TTM 3.58b)
Total Stockholder Equity = 22.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.91% (Net Income 5.07b / Total Assets 129.67b)
RoE = 22.04% (Net Income TTM 5.07b / Total Stockholder Equity 22.98b)
RoCE = 24.51% (EBIT 7.39b / Capital Employed (Equity 22.98b + L.T.Debt 7.17b))
RoIC = 15.85% (NOPAT 4.91b / Invested Capital 30.99b)
WACC = 6.25% (E(160.05b)/V(173.57b) * Re(6.70%) + D(13.52b)/V(173.57b) * Rd(1.34%) * (1-Tc(0.34)))
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.03%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈2.83b ; Y1≈3.49b ; Y5≈5.96b
Fair Price DCF = 128.5 (DCF Value 101.41b / Shares Outstanding 789.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -7.94 | EPS CAGR: 7.66% | SUE: 0.71 | # QB: 0
Revenue Correlation: 32.15 | Revenue CAGR: 1.28% | SUE: 0.58 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.77 | Chg30d=+0.455 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=7.98 | Chg30d=+0.144 | Revisions Net=+9 | Growth EPS=+20.0% | Growth Revenue=+11.8%